AI Terminal
KINOVO PLC
Declaration of Voting Results & Voting Rights Announcements • Aug 31, 2023
7745_rns_2023-08-31_0143864c-4dc7-4cff-8aa4-52ae731a53b6.html
Declaration of Voting Results & Voting Rights Announcements
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 0273L
Kinovo PLC
31 August 2023
31 August 2023
Kinovo plc
("Kinovo", or the "Group")
Total Voting Rights
In accordance with section 5.6.1 of the Financial Conduct Authority's (FCA) Disclosure Guidance and Transparency Rules (DTRs), the Group hereby notifies the market of the following:
The Group's issued capital as at 31 August 2023, consists of 62,788,214 ordinary shares of 10 pence each (Ordinary Shares) with voting rights attached. Of these, no Ordinary Shares are held in Treasury.
Therefore, the total number of voting rights in Kinovo as at 31 August 2023 is 62,788,214.
Shareholders may use the figure of 62,788,214 Ordinary Shares as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in Kinovo under the DTRs.
Enquiries
| Kinovo plc | |
| Sangita Shah, Chair David Bullen, Chief Executive Officer |
+44 (0)20 7796 4133 (via Hudson Sandler) |
| Canaccord Genuity Limited (Nominated Adviser and Sole Broker) | +44 (0)20 7523 8000 |
| Adam James Andrew Potts Harry Rees |
|
| Hudson Sandler (Financial PR) | + 44 (0)20 7796 4133 |
| Dan de Belder Harry Griffiths |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TVREAXPFDAKDEFA